Previously, we provided preliminary data showing that the expression levels of both mature miR-34a and pre-miR-34a (Figure 1A) are significantly reduced in TP53-mutated compared to TP53 WT prostate tumors [5]. This evidence concerns the gene TP53 and prostate neoplasm.